ANZEMET

LIVE

Serial Number

99203944

Owner

VALIDUS PHARMACEUTICALS LLC

Attorney

Charles T. J. Weigell

Filing Date

May 27, 2025

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ANZEMET Trademark

Serial Number: 99203944

ANZEMET is a trademark filed by VALIDUS PHARMACEUTICALS LLC on May 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

VALIDUS PHARMACEUTICALS LLC (34 trademarks)

PARSIPPANY, NJ 07054

Entity Type: 16

Legal Representation

Attorney of Record

Charles T. J. Weigell

3,429 trademarks filed View all →

Correspondence Address

Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.

151 W. 42nd Street, 17th Floor

New York, NY 10036

United States

Trademark Details

Filing Date

May 27, 2025

Registration Date

Not Registered

Published for Opposition

October 28, 2025

Goods & Services

Pharmaceutical preparations for the treatment of nausea, vomiting and headaches

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 23, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 28, 2025 NPUB

PUBLISHED FOR OPPOSITION

Oct 28, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 22, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 29, 2025 CNSA

ASSIGNED TO EXAMINER

Sep 29, 2025 DOCK

APPLICATION FILING RECEIPT MAILED

May 27, 2025 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 27, 2025 NWOS

NEW APPLICATION ENTERED

May 27, 2025 NWAP

Related Trademarks

More from this Owner

TRENTAL

KERLONE

PRIMACOR

More in Same Class

HAPPYUMMMM

DIETARY SUPPLEMENTS, OVER THE COUNTER PRODUCTS, NUTRACEUTICALS AND PHYTO-PHARMACEUTICALS FOR USE IN BONE AND JOINT CONDITIONS. PHARMACEUTICAL AND NUTRACEUTICAL MIXTURES CONSISTING OF A SYNERGISTIC AND SPECIALIZED BLEND OF CERTAIN NATURAL PLANT-BASED INGREDIENTS IN TABLET, CAPSULE, ORAL LIQUIDS, TOPICAL PREPARATIONS AND ANY OTHER DOSAGE FORMS TO BE USED FOR BONE AND JOINT, AND DEGENERATIVE CONDITIONS.